The Nairobi Hospital board has passed a resolution sacking its Chief Executive CEO Dr Allan Pamba barely six months after his appointment.
According to Dr Irungu Ndirangu, the Board Chair, Pamba’s probation period would not be extended because he had failed to provide a performance improvement plan.
“The Board of Management sitting on 2nd October 2020 resolved not to confirm you but terminate your contract following your failure to execute the probation extension and pay you two (2) weeks in lieu of notice. You will be required to hand over all Hospital’s properties in your custody and clear with the Human Resources Department as per the set down clearance procedures. Your last day of working will be 3 rd October 2020” Ndirangu said.
Dr Pamba who was serving on a probationary period was named CEO in March, taking over from Dr Christopher Abeid who served as the acting CEO following the ouster of former CEO Gordon Odundo who was fired in April last year.
Prior to his appointment, Pamba was vice president of global health at GlaxoSmithKline (GSK)- a British multinational pharmaceutical company headquartered in Brentford, London.
